购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
顶部生物活性储存和溶解信息计算器

Anti-HVEM Antibody-FITC (8R903)

Rating icon 还可以
Anti-HVEM Antibody-FITC (8R903)
产品编号 TMAY-00635F
别名 tumor necrosis factor receptor superfamily, member 14, TR2, LIGHTR, HVEM, HVEA, CD270, ATAR

Anti-HVEM Antibody-FITC (8R903) 是一种 FITC-conjugated Rabbit 抗体，靶向 HVEM。Anti-HVEM Antibody-FITC (8R903) 可用于 FCM。

Anti-HVEM Antibody-FITC (8R903)
331

Anti-HVEM Antibody-FITC (8R903)

Rating icon 还可以
Anti-HVEM Antibody-FITC (8R903)
产品编号 TMAY-00635F 别名 tumor necrosis factor receptor superfamily, member 14, TR2, LIGHTR, HVEM, HVEA, CD270, ATAR

Anti-HVEM Antibody-FITC (8R903) 是一种 FITC-conjugated Rabbit 抗体，靶向 HVEM。Anti-HVEM Antibody-FITC (8R903) 可用于 FCM。

规格价格库存数量
25 T
¥ 680
5日内发货
100 T
¥ 2,190
5日内发货
大包装 & 定制
加入购物车
TargetMol 的所有产品仅用作科学研究或药证申报，不能被用于人体，我们不向个人提供产品和服务。请您遵守承诺用途，不得违反法律法规规定用于任何其他用途。
实验操作小课堂
常见问题解答
查看更多
联系我们获取更多批次信息
资源下载
产品操作手册

产品介绍

生物活性
产品描述
Anti-HVEM Antibody-FITC (8R903) is a FITC-conjugated Rabbit antibody targeting HVEM. Anti-HVEM Antibody-FITC (8R903) can be used in FCM.
别名tumor necrosis factor receptor superfamily, member 14, TR2, LIGHTR, HVEM, HVEA, CD270, ATAR
Ig Type
Rabbit IgG
克隆号
8R903
交叉反应
Human
验证活性
Flow cytometric analysis of Human HVEM(CD270) expression on human whole blood lymphocytes. Cells were stained with FITC-conjugated anti-Human HVEM(CD270). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.
应用
FCM
推荐剂量
10 μl/Test, 0.1 mg/ml
抗体种类
Monoclonal
宿主来源Rabbit
构建方式This antibody was obtained from a rabbit immunized with purified, recombinant Human HVEM/TNFRSF14/CD270 (rh HVEM/TNFRSF14/CD270; TMPY-01750; NP_003811.2; Met1-Val202) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
纯化方式Protein A
性状Liquid
缓冲液PBS solution containing 0.5% BSA and 0.09% sodium azide
研究背景Herpesvirus entry mediator (HVEM), also referred to as TNFRSF14, TR2 (TNF receptor-like molecule) and ATAR (another TRAF-associated receptor), is a member of type I transmembrane protein belonging to the TNF-receptor superfamily. It is expressed on many immune cells, including T and B cells, NK cells, monocytes, and neutrophils. Two TNF superfamily ligands lymphotoxin α (TNF-β) and LIGHT (TNFSF14) are identified as cellular ligands for HVEM and initiate the positive signaling. However, recent studies have revealed that HVEM is also involved in the unique inhibitory signaling pathway for T cells through activating tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif (ITIM) in B and T lymphocyte attenuator (BTLA). HVEM provides a stimulatory signal following engagement with LIGHT (TNFSF14) on T cells. In contrast, it can also provide an inhibitory signal to T cells when it binds the B and T lymphocyte attenuator (BTLA), a ligand member of the Immunoglobulin (Ig) superfamily. Thus, HVEM may be viewed as a molecular switch, capable of facilitating both stimulatory and inhibitory cosignaling in T cells. Substantial evidence from both human disease and from experimental mouse models has indicated that dysregulation of the LIGHT-HVEM-BTLA cosignaling pathway can cause inflammation in the lung and in mucosal tissues.Cancer ImmunotherapyCo-inhibitory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy
偶联与修饰
偶联
FITC
其他可选修饰符
Unconjugated/APC/PE
可提供抗体种类
4
抗原信息
免疫原
Recombinant Protein: Human HVEM/TNFRSF14/CD270 Protein (TMPY-01750)
抗原种属
Human
研究领域
Cancer Drug Targets
存储&运输
储存方式Store at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight. Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
运输方式Shipping with blue ice.

计算器

  • 稀释 计算器

关键词

TR-2TR 2CD-270CD 270

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

233
Related Tags: buy Anti-HVEM Antibody-FITC (8R903) | purchase Anti-HVEM Antibody-FITC (8R903) | Anti-HVEM Antibody-FITC (8R903) cost | order Anti-HVEM Antibody-FITC (8R903)